Sbi Securities Co., Ltd. Bio Atla, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Bio Atla, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 4,115 shares of BCAB stock, worth $2,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,115
Previous 825
398.79%
Holding current value
$2,057
Previous $488,000
192.42%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCAB
# of Institutions
68Shares Held
22.9MCall Options Held
30.8KPut Options Held
57K-
Anson Funds Management LP Dallas, TX4.6MShares$2.3 Million0.35% of portfolio
-
Acorn Capital Advisors, LLC New York, NY4.03MShares$2.02 Million1.29% of portfolio
-
Highbridge Capital Management LLC New York, NY2.51MShares$1.25 Million0.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$916,2380.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$687,0380.06% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $18.2M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...